Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2025-12-24 @ 11:36 PM
NCT ID:
NCT01603056
Eligibility Criteria:
Inclusion Criteria:
* Male or female ≥ 5 to ≤ 55 years of age.
* A history HDM induced allergic rhinitis.
* Use of medication for the control of rhinoconjunctivitis symptoms.
* Positive Skin Prick Test (SPT).
* Positive specific IgE.
Exclusion Criteria:
* PEF ≤ 70% of predicted value.
* History of significant symptomatic seasonal or perennial allergic rhinitis and/or asthma caused by an allergen to which the patient is regularly exposed, and sensitized (e.g. pollens, cat, dog, cockroach…except house dust mites).
* Severe asthma.
* Current symptoms of upper respiratory tract infection or other relevant infectious process.
* Current food allergies with oral allergy syndrome.
* A clinical history of chronic sinusitis.
* Current severe atopic dermatitis.
* Concomitant or previous treatment by immunotherapy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
5 Years
Maximum Age:
55 Years
Study:
NCT01603056
Study Brief:
Protocol Section:
NCT01603056